Cohen Capital Management, Inc. Oncternal Therapeutics, Inc. Transaction History

Cohen Capital Management, Inc.

  • $602 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021
SELL
$1.51 - $6.3 $19,699 - $82,189
-13,046 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$4.86 - $9.24 $63,403 - $120,545
13,046 New
13,046 $87,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $79.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Cohen Capital Management, Inc. Portfolio

Follow Cohen Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cohen Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email